Chemotherapy Acute Infusion Reactions: A Qualitative Report of the Perspectives of Patients With Cancer

Am J Hosp Palliat Care. 2018 Nov;35(11):1384-1389. doi: 10.1177/1049909118773995. Epub 2018 May 3.

Abstract

Objective: A growing number of cancer antineoplastic agents can cause life-threatening acute infusion reactions. Because previous studies have not studied these reactions from the perspective of patients, this study was undertaken with that objective in mind.

Methods: Patients who had an acute infusion reaction were interviewed based on the Leventhal model. Once saturation of content was achieved, interviews were transcribed and analyzed with qualitative methodology.

Results: Twenty-one patients were enrolled. Most were women (n = 15); the median age was 58 years, and paclitaxel was the most common inciting agent. Three themes emerged. First, these reactions are frightening; patients made remarks such as "I was just thinking oh my God, I am dying." Second, prior education about these reactions seemed to mitigate this fear, "Basically everything the nurses told me potentially could happen, like happened. So, I was prepared." Third, when health-care providers were prompt and attentive during the reaction, patients described less fear with future chemotherapy, "So no, I'm really not fearful about going in tomorrow because I know they'll be there and they'll be watching me."

Conclusion: These reactions evoke fear which can be mitigated with education prior to and with prompt responsiveness during the acute infusion reaction.

Keywords: carboplatin; education; infusion reactions; oxaliplatin; paclitaxel; qualitative.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Attitude of Health Personnel
  • Female
  • Humans
  • Infusions, Intravenous
  • Injection Site Reaction / psychology*
  • Interviews as Topic
  • Male
  • Middle Aged
  • Neoplasms / drug therapy*
  • Patient Education as Topic
  • Qualitative Research
  • Young Adult

Substances

  • Antineoplastic Agents